1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-吗啉-1H-吡唑-3-甲酰胺
中文名称 | 1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-吗啉-1H-吡唑-3-甲酰胺 |
---|---|
中文同义词 | 1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-4-吗啉基-1H-吡唑-3-甲酰胺;1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-吗啉-1H-吡唑-3-甲酰胺;1-(2,4-二氯苯)-5-(4-碘苯基)-4-甲基-N-4-吗啉基-1H-吡唑-3-甲酰胺;化合物AM281 |
英文名称 | 1-(2,4-DICHLOROPHENYL)-5-(4-IODOPHENYL)-4-METHYL-N-4-MORPHOLINYL-1H-PYRAZOLE-3-CARBOXAMIDE |
英文同义词 | AM-281 ,99%;1-(2,4-DICHLOROPHENYL)-5-(4-IODOPHENYL)-4-METHYL-N-4-MORPHOLINYL-1H-PYRAZOLE-3-CARBOXAMIDE;AM 281;1-(2,4-Dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-4-morpholinyl-1H-pyrazole-3-carboxamide AM 281;1H-Pyrazole-3-carboxamide,1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-4-morpholinyl-;CS-1127;AM281;AM-281;1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-morpholin-4-ylpyrazole-3-carboxamide |
CAS号 | 202463-68-1 |
分子式 | C21H19Cl2IN4O2 |
分子量 | 557.21 |
EINECS号 | |
相关类别 | 小分子抑制剂;小分子抑制剂,天然产物;Inhibitors;Cannabinoid receptor;Cannabinoids. |
Mol文件 | 202463-68-1.mol |
结构式 |
1-(2,4-二氯苯基)-5-(4-碘苯基)-4-甲基-N-吗啉-1H-吡唑-3-甲酰胺 性质
密度 | 1.70±0.1 g/cm3(Predicted) |
---|---|
储存条件 | 2-8°C |
溶解度 | 二甲基亚砜:>6 mg/mL |
形态 | 固体 |
酸度系数(pKa) | 10.76±0.20(Predicted) |
颜色 | 白色 |
CB1 9.91 nM (IC 50 ) |
CB2 13000 nM (IC 50 ) |
AM281 (0.01-10 μM) promotes a concentration dependent increase in 10 μM Aβ 25-35 induced neurotoxicity in SH-SY5Y cells in the presence of 10 μM KSO 1-6.
Acute administration (2.5, 5 and 10 mg/kg) of AM281 shortens exploration time and improves memory performance, as does chronic administration (0.62, 1.25 and 2.5 mg/kg) of AM281.
Chronic administration of AM281 at 2.5 mg/kg improves recognition index to the 22.1±4.8 and single dose of AM281 at 5 mg/kg improves the memory impairment to the 8.5±4, as compared with vehicle-treated which is 4.8±2.5. Administration of AM281 at a dose of 2.5 mg/kg in chronic form and 5 mg/kg in acute dose improve memory.
Animal Model: | Male NMRI mice with the weight of 25-30 g |
Dosage: | 0.62, 1.25 and 2.5 mg/kg (chronic administration); 2.5, 5 and 10 mg/kg (acute administration) |
Administration: | Administrated i.p. every day concurrently with morphine except the day of experiment (chronic administration); Singly injected 40 min before second trial (acute administration) |
Result: |
The simultaneous daily administration of AM281 with morphine significantly shortened the exploration time, as compared with morphine-dependent mice receiving vehicle.
Acute administration at a dose of 5 mg/kg, significantly augmented recognition index. |
安全信息
危险品标志 | T |
---|---|
危险类别码 | 25-36/37/38 |
安全说明 | 26-36/37/39-45 |
危险品运输编号 | UN 2811 6.1/PG 3 |
WGK Germany | 3 |
提供商 | 语言 |
---|---|
英文
|